நவீன் ஜாகோப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நவீன் ஜாகோப். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நவீன் ஜாகோப் Today - Breaking & Trending Today

Intercept Pharmaceuticals Inc (ICPT) Q1 2021 Earnings Call Transcript

Operator
Welcome to the Q1 2021 Intercept Pharmaceuticals Earnings Call. My name is Anette, and I ll be your operator for today s call. [Operator Instructions]
I will now turn the call over to Lisa DeFrancesco. Lisa, you may begin.
Lisa DeFrancesco
Senior Vice President of Investor Relations and Corporate Affairs
Thank you. Good morning, and thank you for joining us on today s call. This morning, we issued a press release announcing our first quarter 2021 results and financial position, which is available on our website at www.interceptpharma.com. Before we begin our discussion, I d like to note that during our call, we will be making forward-looking statements, including statements regarding our approved product and clinical development program; certain regulatory matters; and our strategy, prospects, financial guidance and future commercial and financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, w ....

United States , Gail Cawkwell , Jerome Durso , Raymond James , Chris Weyer , Linda Richardson , Steve Seedhouse , Jay Olson Oppenheimer , Lisa Defrancesco , Michael Yee , Jerry Durso , Brian Abrahams , Jay Olson , Rocco Venezia , David Cithu , Mark Pruzanski , Ryan Deschner , Piper Sandler , Jesse Piper Sandler , Navin Jacob , Ryan Deschner Raymond James , Thomas Smith , Emily Cantor Fitzgerald , Cantor Fitzgerald , Intercept Pharmaceuticals Inc , Intercept Pharmaceuticals Earnings Call ,

Alnylam Pharmaceuticals Inc (ALNY) Q1 2021 Earnings Call Transcript

Alnylam Pharmaceuticals Inc (ALNY) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY)
Q1 2021 Earnings Call
Operator
Thank you for standing by and welcome to the Alnylam Pharmaceuticals First Quarter 2021 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder today s program is being recorded.
And now I d like to introduce your host for today s program, Christine Lindenboom, Senior Vice President of Investor Relations and Corporate Communications. Please go ahead.SPONSORED: ....

United States , City Of , United Kingdom , Christine Lindenboom , Akshay Vaishnaw , Jeff Poulton , Tolga Tanguler , Gena Wang , Debjit Chattopadhyay , Alethia Young , Paul Matteis Stifel , David Lebowitz Morgan Stanley , Alethia Young Cantor Fitzgerald , Paul Matteis , John Maraganore , Gena Wang Barclays , Salveen Richter , Akshay Vaishna , David Lebowitz , Maury Raycroft , Sonya Bhatia Goldman Sachs , Navin Jacob , Maury Raycroft Jefferies , Tazeen Ahmad , Yvonne Greenstreet , Rd Jeff Poulton ,

BioNTech SE (BNTX) Q4 2020 Earnings Call Transcript

BioNTech SE (BNTX) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
BioNTech SE (NASDAQ: BNTX)
Good day and thank you for standing by. Welcome to BioNTech s corporate update and financial results fourth-quarter and full-year 2020 conference call. [Operator instructions] Please be advised today s conference is being recorded. [Operator instructions] Now, I d like to hand the conference over to your first speaker today, Sylke Maas, vice president, investor relations and strategy.
Please go ahead.
Vice President, Investor Relations and Strategy
Thank you. Good morning and good afternoon. Thank you for joining us today to review BioNTech s fourth-quarter and full-year 2020 operational progress and financial results. Before we start, we encourage you to view the slides for this webcast, as well as the operational and financial results press release issued this morni ....

Idar Oberstein , Rheinland Pfalz , United States , Hong Kong , United Kingdom , South Africa , South African , Canaccord Genuity , Cory Kasimov , Albert Bourla , Daina Graybosch , Arlinda Lee , Ryan Richardson , Fosun Pharma , Sylke Maas , Daniel Wendorff Commerzbank , Biontech Marburg , Roche Genentech , Sierk Poetting , America Merrill Lynch , Ozlem Tureci , Regeneron Libtayo , Arlinda Lee Canaccord Genuity , Akash Tewari , Sean Marett , Cory Kasimov Jpmorgan ,

FDA Advisory Panel To Review Johnson Johnson COVID 19 Vaccine With Thumbs Up Expected

J&J s vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response., , Johnson & Johnson, BioNTech, COVID-19 Vaccine, united states ....

South Africa , United States , Navin Jacob , Us Centers For Disease , Moderna Inc , Drug Administration , Pfizer Inc Biontech , Disease Control , Johnson Amp , Covid 19 Vaccine , ஒன்றுபட்டது மாநிலங்களில் , நவீன் ஜாகோப் , எங்களுக்கு மையங்கள் க்கு நோய் , மாடர்னா இன்க் , நோய் கட்டுப்பாடு , ஜான்சன் ஆம்ப் ,

Advisors expected to recommend FDA O.K. for J&J's one-dose vaccine today

Johnson & Johnson s one-dose COVID-vaccine could get FDA approval within DAYS: Advisors meeting today to discuss emergency authorization for the shot - but it may not get green-lit for over-75s
FDA s advisory committee is meeting to debate whether to recommend emergency authorization for J&J s one-dose vaccine
The shot was 66% effective at preventing mild to moderate infection in trials
It prevented 100% of deaths from COVID-19 and virtually all hospitalizations
J&J s data on elderly people was thin, so its shot may not be authorized for Americans over 75
J&J said it can only provide three to four million doses upon authorization, which could come Saturday ....

South Africa , United States , Navin Jacob , Us Centers For Disease , Moderna Inc , Drug Administration , Pfizer Inc Biontech , Disease Control , ஒன்றுபட்டது மாநிலங்களில் , நவீன் ஜாகோப் , எங்களுக்கு மையங்கள் க்கு நோய் , மாடர்னா இன்க் , நோய் கட்டுப்பாடு ,